EFHD2 antibody (N-Term)
Quick Overview for EFHD2 antibody (N-Term) (ABIN631302)
Target
See all EFHD2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- EFHD2 antibody was raised against the N terminal of EFHD2
-
Purification
- Affinity purified
-
Immunogen
- EFHD2 antibody was raised using the N terminal of EFHD2 corresponding to a region with amino acids MGTPGEGLGRCSHALIRGVPESLASGEGAGAGLPALDLAKAQREHGVLGG
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
EFHD2 Blocking Peptide, (ABIN5613315), is also available for use as a blocking control in assays to test for specificity of this EFHD2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EFHD2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EFHD2 (EF-Hand Domain Family, Member D2 (EFHD2))
-
Alternative Name
- EFHD2
-
Background
- EFHD2 may regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. It plays a role as negative regulator of the canonical NF-kappa-B-activating branch. EFHD2 controls spontaneous apoptosis through the regulation of BCL2L1 abundance.
-
Molecular Weight
- 26 kDa (MW of target protein)
Target
-